scholarly article | Q13442814 |
P819 | ADS bibcode | 2003PNAS..100.7283B |
P356 | DOI | 10.1073/PNAS.1237725100 |
P8608 | Fatcat ID | release_d3ujb36uxfdtfon56amimnj3iq |
P932 | PMC publication ID | 165867 |
P698 | PubMed publication ID | 12771386 |
P5875 | ResearchGate publication ID | 10739846 |
P50 | author | Nancy Andrews | Q4793337 |
Michael H. Picard | Q37386535 | ||
Michael Simons | Q39375925 | ||
P2093 | author name string | Monty Krieger | |
Mark J Post | |||
Anne Braun | |||
Helena E Miettinen | |||
Eliza Vasile | |||
Danita M Yoerger | |||
Joshua L Krieger | |||
Shamsah Ebrahim | |||
Songwen Zhang | |||
Teresa M Holm | |||
P2860 | cites work | High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner | Q24292170 |
A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism | Q24646308 | ||
Method for non-invasively recording electrocardiograms in conscious mice | Q24801627 | ||
Inflammation in acute coronary syndromes | Q28193283 | ||
Identification of scavenger receptor SR-BI as a high density lipoprotein receptor | Q28273182 | ||
Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems | Q28354246 | ||
Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice | Q28365792 | ||
Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile | Q28507887 | ||
Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo | Q28511213 | ||
Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 | ||
Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice | Q31961261 | ||
Apolipoprotein E: a cholesterol transport protein with lipid transport-independent cell signaling properties | Q32068720 | ||
Effect of probucol in lecithin-cholesterol acyltransferase-deficient mice: inhibition of 2 independent cellular cholesterol-releasing pathways in vivo | Q32085481 | ||
Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipase | Q33604083 | ||
Dyslipoproteinaemia of liver disease | Q33688775 | ||
Probucol suppresses ICAM-1 expression in rat mesangial cells: possible role of IL-1. | Q33690971 | ||
Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. | Q33953583 | ||
Apolipoprotein E and atherosclerosis | Q33959445 | ||
Adriamycin-induced heart failure: mechanism and modulation | Q33963576 | ||
Probucol | Q34107317 | ||
Oxidants and antioxidants in atherosclerosis | Q34338340 | ||
Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia | Q34340579 | ||
Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros | Q34360883 | ||
Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology | Q35603368 | ||
Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption | Q36288943 | ||
Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice | Q36385620 | ||
Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad | Q37348207 | ||
Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice | Q37368611 | ||
High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase | Q38299352 | ||
Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia | Q38672462 | ||
Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits. | Q41700988 | ||
Metabolism of HDL-cholesteryl ester in the rat, studied with a nonhydrolyzable analog, cholesteryl linoleyl ether | Q42259584 | ||
Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient mice | Q42537447 | ||
Endothelial apoptosis induced by oxidative stress through activation of NF-kappaB: antiapoptotic effect of antioxidant agents on endothelial cells | Q43681941 | ||
Anti-atherogenic antioxidants regulate the expression and function of proteasome alpha-type subunits in human endothelial cells | Q43726517 | ||
Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice | Q43729308 | ||
Probucol treatment in hypercholesterolemic patients: effects on lipoprotein composition, HDL particle size, and cholesteryl ester transfer | Q43805131 | ||
Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST). | Q43890114 | ||
Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI. | Q43893087 | ||
Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice | Q43893171 | ||
The effects of mutations in helices 4 and 6 of ApoA-I on scavenger receptor class B type I (SR-BI)-mediated cholesterol efflux suggest that formation of a productive complex between reconstituted high density lipoprotein and SR-BI is required for ef | Q43908322 | ||
Effect of BO-653 and probucol on c-MYC and PDGF-A messenger RNA of the iliac artery after balloon denudation in cholesterol-fed rabbits. | Q43912985 | ||
Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat. | Q44009245 | ||
Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation | Q44064973 | ||
Probucol increases the selective uptake of HDL cholesterol esters by Hep G2 human hepatoma cells | Q44308720 | ||
Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels | Q45881945 | ||
Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I. | Q45998910 | ||
Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice | Q46141600 | ||
Echocardiographic determination of risk area size in a murine model of myocardial ischemia | Q47257697 | ||
Familial lecithin:cholesterol acyltransferase deficiency--a clinical survey. | Q54135509 | ||
Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein | Q62383302 | ||
Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosis | Q68095783 | ||
Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression | Q72690003 | ||
Effects of dietary fat levels on the absorption and tissue accumulation of probucol in the rat | Q72871646 | ||
Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor | Q72992440 | ||
Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse | Q73295343 | ||
Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group | Q73552611 | ||
Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux | Q73596081 | ||
Site-specific antiatherogenic effect of probucol in apolipoprotein E-deficient mice | Q74152611 | ||
Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels | Q74471880 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | heart disease | Q190805 |
coronary artery disease | Q844935 | ||
knockout mouse | Q1364740 | ||
P304 | page(s) | 7283-7288 | |
P577 | publication date | 2003-05-27 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse | |
P478 | volume | 100 |
Q37211062 | "Who's on first": determining the roster for the key players in the reverse cholesterol transport pathway |
Q44989237 | 5th Annual International Conference on HDL Cholesterol: metabolic pathways and drug developments |
Q37109628 | Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds |
Q36843340 | ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis |
Q58737823 | Attenuation of atherogenic apo B-48-dependent hyperlipidemia and high density lipoprotein remodeling induced by vitamin C and E combination and their beneficial effect on lethal ischemic heart disease in mice |
Q33435708 | Carboxy-terminal deletion of the HDL receptor reduces receptor levels in liver and steroidogenic tissues, induces hypercholesterolemia, and causes fatal heart disease |
Q34948139 | Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis |
Q27313306 | Dietary manipulation and social isolation alter disease progression in a murine model of coronary heart disease |
Q99567286 | Differential roles of Scavenger receptor class B type I: A protective molecule and a facilitator of atherosclerosis (Review) |
Q55339140 | Effect of probucol on hemodynamics, rheology and blood lipid of diabetic retinopathy. |
Q57113067 | Effects of mulberry leaf on experimental hyperlipidemia rats induced by high-fat diet |
Q34581244 | Excess cholesterol induces mouse egg activation and may cause female infertility. |
Q28390580 | Exposure to moderate arsenic concentrations increases atherosclerosis in ApoE-/- mouse model |
Q30528268 | Extrahepatic high-density lipoprotein receptor SR-BI and apoA-I protect against deep vein thrombosis in mice. |
Q34998020 | Glycine dimerization motif in the N-terminal transmembrane domain of the high density lipoprotein receptor SR-BI required for normal receptor oligomerization and lipid transport |
Q38293430 | HDL biogenesis, remodeling, and catabolism. |
Q36765386 | HDL signaling and protection against coronary artery atherosclerosis in mice |
Q36232365 | Hepatic high-density lipoprotein receptors: roles in lipoprotein metabolism and potential for therapeutic modulation |
Q37584875 | High-density lipoprotein metabolism and the human embryo. |
Q57817035 | Hyperglycemia Aggravates Diet-Induced Coronary Artery Disease and Myocardial Infarction in SR-B1-Knockout/ApoE-Hypomorphic Mice |
Q37240487 | Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease |
Q27664175 | In Vitro and in Vivo Analysis of the Binding of the C Terminus of the HDL Receptor Scavenger Receptor Class B, Type I (SR-BI), to the PDZ1 Domain of Its Adaptor Protein PDZK1 |
Q36708971 | Influence of PDZK1 on lipoprotein metabolism and atherosclerosis |
Q36625645 | Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice |
Q30942732 | Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice |
Q57349944 | Nanoparticulation of probucol, a poorly water-soluble drug, using a novel wet-milling process to improvein vitrodissolution andin vivooral absorption |
Q34726050 | Negatively cooperative binding of high-density lipoprotein to the HDL receptor SR-BI |
Q34657849 | Normal hepatic cell surface localization of the high density lipoprotein receptor, scavenger receptor class B, type I, depends on all four PDZ domains of PDZK1. |
Q36628814 | Oral absorption enhancement of probucol by PEGylated G5 PAMAM dendrimer modified nanoliposomes |
Q36808468 | Overexpression of the PDZ1 domain of PDZK1 blocks the activity of hepatic scavenger receptor, class B, type I by altering its abundance and cellular localization |
Q35880331 | Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport |
Q37382165 | Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis |
Q37151611 | Probucol inhibits LPS-induced microglia activation and ameliorates brain ischemic injury in normal and hyperlipidemic mice |
Q45275694 | Probucol protects against hypochlorite-induced endothelial dysfunction: identification of a novel pathway of probucol oxidation to a biologically active intermediate. |
Q37108304 | Progression and disruption of advanced atherosclerotic plaques in murine models |
Q57123755 | Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins |
Q64237412 | Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability |
Q36406570 | Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. |
Q33767978 | Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI |
Q47377607 | Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering |
Q34965254 | SR-BI in bone marrow derived cells protects mice from diet induced coronary artery atherosclerosis and myocardial infarction |
Q36227219 | SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance |
Q39161542 | SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis |
Q37639147 | Scavenger Receptor Class B Type 1 Deletion Led to Coronary Atherosclerosis and Ischemic Heart Disease in Low-density Lipoprotein Receptor Knockout Mice on Modified Western-type Diet |
Q33567588 | Scavenger receptor BI and high-density lipoprotein regulate thymocyte apoptosis in sepsis |
Q35215415 | Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia |
Q92051453 | Selective Correction of Genotype Yield by Probucol in HDL-Deficient Mice Propagation |
Q51804653 | Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BI. |
Q53571308 | Severely altered cholesterol homeostasis in macrophages lacking apoE and SR-BI. |
Q51600809 | Supercritical fluid chromatography with tandem mass spectrometry combined with postcolumn compensation and one-step acetone protein precipitation to evaluate the bioavailability of probucol solid dispersion tablet. |
Q33937822 | Susceptibility gene for stroke or cerebral infarction in the Han population in Hunan Province of China |
Q28208721 | Targeted Disruption of the PDZK1 Gene in Mice Causes Tissue-specific Depletion of the High Density Lipoprotein Receptor Scavenger Receptor Class B Type I and Altered Lipoprotein Metabolism |
Q35952837 | Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors |
Q37981725 | Therapeutic strategies to deplete macrophages in atherosclerotic plaques |
Q33379402 | Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice |
Q64990442 | Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient mice. |